EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 239 filers reported holding EDITAS MEDICINE INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,004,000 | -35.4% | 403,581 | -3.5% | 0.64% | -15.3% |
| Q4 2019 | $12,381,000 | +47.0% | 418,151 | +22.8% | 0.76% | +30.0% |
| Q3 2019 | $8,421,000 | -16.0% | 340,442 | -16.0% | 0.58% | +8.8% |
| Q2 2019 | $10,024,000 | -13.5% | 405,239 | -14.5% | 0.54% | -0.4% |
| Q1 2019 | $11,590,000 | +15.9% | 474,065 | +7.8% | 0.54% | -0.7% |
| Q4 2018 | $10,004,000 | -34.7% | 439,757 | -8.7% | 0.54% | -9.8% |
| Q3 2018 | $15,323,000 | -15.6% | 481,568 | -5.0% | 0.60% | -9.6% |
| Q2 2018 | $18,164,000 | +15.6% | 506,917 | +7.0% | 0.67% | +23.6% |
| Q1 2018 | $15,711,000 | -16.7% | 473,949 | -22.8% | 0.54% | -13.3% |
| Q4 2017 | $18,869,000 | +39.1% | 614,052 | +8.7% | 0.62% | +43.3% |
| Q3 2017 | $13,566,000 | – | 565,041 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |